https://www.alphaview.kr 실시간 미국 주식 뉴스를 AI로 분석하여 시장 정보를 제공합니다. ko Sun, 03 May 2026 21:07:20 GMT https://www.alphaview.kr/images/brand/logo.png https://www.alphaview.kr Copyright 2026 AlphaView. All rights reserved. contact@alphaview.kr (AlphaView) contact@alphaview.kr (AlphaView) 30 https://www.alphaview.kr/news/31888-acurx-pharmaceuticals-inc-마켓-무버스-투자자-서밋-참가-예정 Mon, 27 Apr 2026 12:04:33 GMT https://www.alphaview.kr/news/31888-acurx-pharmaceuticals-inc-마켓-무버스-투자자-서밋-참가-예정 바이오/헬스케어 newsfilecorp Newsfile Corp https://www.alphaview.kr/news/28198-acurx-pharmaceuticals-inc-나스닥-규정에-따라-시장가로-책정된-최대-710만-달러-규모의-등록-직접-공모-완료-발표 Thu, 16 Apr 2026 20:02:16 GMT https://www.alphaview.kr/news/28198-acurx-pharmaceuticals-inc-나스닥-규정에-따라-시장가로-책정된-최대-710만-달러-규모의-등록-직접-공모-완료-발표 금융/자금조달 prnewswire PR Newswire https://www.alphaview.kr/news/22019-acurx-pharmaceuticals-dna-polymerase-iiic-억제제에-대한-한국-특허-획득 Mon, 30 Mar 2026 11:02:23 GMT https://www.alphaview.kr/news/22019-acurx-pharmaceuticals-dna-polymerase-iiic-억제제에-대한-한국-특허-획득 바이오/헬스케어 prnewswire PR Newswire https://www.alphaview.kr/news/18387-acurx-pharmaceuticals-inc-연간-및-4분기-실적-발표-및-사업-업데이트 Fri, 13 Mar 2026 11:03:00 GMT https://www.alphaview.kr/news/18387-acurx-pharmaceuticals-inc-연간-및-4분기-실적-발표-및-사업-업데이트 바이오/헬스케어 prnewswire PR Newswire https://www.alphaview.kr/news/16708-acurx-재발성-cdi-환자-대상-새로운-이베자폴스타트-임상시험-프로그램-발표-치료-및-예방-패러다임-전환-가능성 Mon, 09 Mar 2026 12:02:30 GMT https://www.alphaview.kr/news/16708-acurx-재발성-cdi-환자-대상-새로운-이베자폴스타트-임상시험-프로그램-발표-치료-및-예방-패러다임-전환-가능성 바이오/헬스케어 prnewswire PR Newswire https://www.alphaview.kr/news/2877-acurx-pharmaceuticals-2025년-연간-및-4분기-재무-결과-발표-및-사업-업데이트-예정 Mon, 16 Feb 2026 13:02:11 GMT https://www.alphaview.kr/news/2877-acurx-pharmaceuticals-2025년-연간-및-4분기-재무-결과-발표-및-사업-업데이트-예정 바이오/헬스케어 prnewswire PR Newswire